Twist Bioscience Corporation (NASDAQ:TWST) will release earnings results for its fourth quarter, before the opening bell on Monday, Nov. 18.
Analysts expect the South San Francisco, California-based bank to report a quarterly loss at 69 cents per share, versus a year-ago loss of 75 cents per share. Twist Bioscience projects to report revenue of $82.66 million for the recent quarter, compared to $66.95 million a year earlier, according to data from Benzinga Pro.
On Oct. 22, Twist Bioscience entered into royalty purchase agreement with xOMA Royalty for $15 million in cash.
Twist Bioscience shares fell 5.3% to close at $36.89 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
Considering buying TWST stock? Here’s what analysts think:
Read This Next:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
